摘要
目的:探讨Cystatin C在急性白血病中的临床意义。方法:采用颗粒增强透射免疫比浊法测定62例急性白血病患者血清中Cystatin C水平。结果:急性白血病初诊患者血清Cystatin C水平明显低于正常对照组(P<0.05),完全缓解期Cystatin C水平恢复正常,未缓解和复发患者Cystatin C水平与初诊患者无明显差异(P>0.05)。结论:检测血清Cystatin C水平变化有助于急性白血病病情判断,可作为疗效观察的新指标。
Objective:To investigate clinical significance of Cystatin C in patients with acute leukemia.Methods:Serum level of Cystatin C in 62 patients with acute leukemia was determined by particle-enhanced turbidimetric immunoassay.Results:The serum level of Cystatin C in initial patient with acute leukemia was significantly higher than that of control group (P < 0.05),and decreased to normal in patients at complete remission period.There was no difference in Cystatin C between nonremission and relapse and initial patients(P > 0.05).Conclusion:Serum Cystatin C in the patients with acute leukemia is useful marker to judge state of illness,and Cystatin C may be regarded as new index of curative effect.
出处
《现代肿瘤医学》
CAS
2013年第11期2559-2560,共2页
Journal of Modern Oncology